Cargando…

SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia

Folate metabolism enables cell growth by providing one-carbon (1C) units for nucleotide biosynthesis. The 1C units are carried by tetrahydrofolate (THF), whose production by the enzyme DHFR is targeted by the important anticancer drug methotrexate. 1C units come largely from serine catabolism by the...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Cañaveras, Juan C., Lancho, Olga, Ducker, Gregory S., Ghergurovich, Jonathan M., Xu, Xincheng, da Silva-Diz, Victoria, Minuzzo, Sonia, Indraccolo, Stefano, Kim, Hahn, Herranz, Daniel, Rabinowitz, Joshua D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647950/ https://www.ncbi.nlm.nih.gov/pubmed/32382081 http://dx.doi.org/10.1038/s41375-020-0845-6

Ejemplares similares

Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures
por: Franciosa, Giulia, et al.
Publicado: (2021)

PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia
por: Silveira, André Bortolini, et al.
Publicado: (2015)

Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells
por: Pinazza, Marica, et al.
Publicado: (2018)

Targeting NOTCH1 in combination with antimetabolite drugs prolongs life span in relapsed pediatric and adult T-acute lymphoblastic leukemia xenografts
por: Minuzzo, Sonia, et al.
Publicado: (2023)

Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia
por: Verbeke, Delphine, et al.
Publicado: (2019)

SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis
por: Anderson, Donald D., et al.
Publicado: (2009)

An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts
por: Pinazza, M, et al.
Publicado: (2016)

Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia
por: Xiong, Huizhong, et al.
Publicado: (2021)

Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts
por: Agnusdei, Valentina, et al.
Publicado: (2020)

Methionine synthase supports tumor tetrahydrofolate pools
por: Ghergurovich, Jonathan M., et al.
Publicado: (2021)

Case report: Intravitreal methotrexate in intraocular acute lymphoblastic leukemia
por: Pederzolli, Matteo, et al.
Publicado: (2022)

Methotrexate-Mediated Arachnoiditis in a Child with Acute Lymphoblastic Leukemia
por: Karamercan, Sırma, et al.
Publicado: (2022)

Intravitreal methotrexate in type B lymphoblastic leukemia—Case Report
por: Maya Naranjo, Maria Isabel, et al.
Publicado: (2023)

High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia
por: Jastaniah, Wasil, et al.
Publicado: (2018)

Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
por: Liu, Shu-Guang, et al.
Publicado: (2017)

Methotrexate-induced chemical meningitis in patients with acute lymphoblastic leukemia/lymphoma
por: Jacob, Linu A., et al.
Publicado: (2015)

Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
por: Wojtuszkiewicz, Anna, et al.
Publicado: (2015)

MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy
por: Umerez, Maitane, et al.
Publicado: (2017)

Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
por: Ghelli Luserna Di Rorà, Andrea, et al.
Publicado: (2019)

mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells
por: Silic-Benussi, Micol, et al.
Publicado: (2022)

miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia
por: Saccomani, Valentina, et al.
Publicado: (2020)

Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity
por: Abedi, Marjan, et al.
Publicado: (2020)

The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia
por: Shen, Yaqing, et al.
Publicado: (2021)

Intrathecal Methotrexate-Induced Aseptic Meningitis in a Patient with Acute Lymphoblastic Leukemia
por: Tang, Wesley, et al.
Publicado: (2022)

Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines
por: Canevarolo, Rafael Renatino, et al.
Publicado: (2022)

The effects of Astragalus polysaccharides, tragacanthin, and bassorin on methotrexate-resistant acute lymphoblastic leukemia
por: Samii, Bahareh, et al.
Publicado: (2023)

Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia
por: Xu, Meng, et al.
Publicado: (2022)

Cancer proteome and metabolite changes linked to SHMT2
por: Tong, Jiefei, et al.
Publicado: (2020)

Anticancer Conjugates and Cocktails Based on Methotrexate and Nucleoside Synergism
por: Vortherms, Anthony R., et al.
Publicado: (2009)

Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia: Clinical Facts and Fiction
por: Schmiegelow, Kjeld, et al.
Publicado: (2014)

Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia
por: Oosterom, Natanja, et al.
Publicado: (2018)

Efficacy and association analysis of high-dose methotrexate in the treatment of children with acute lymphoblastic leukemia
por: Gong, Fangwei, et al.
Publicado: (2019)

High-Dose Methotrexate-Induced Idiopathic Intracranial Hypertension in Infant Acute Lymphoblastic Leukemia
por: Zhang, Yazhi, et al.
Publicado: (2020)

Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment
por: Kotur, Nikola, et al.
Publicado: (2020)

Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
por: Gao, Xuan, et al.
Publicado: (2021)

Methotrexate-induced Transient Encephalopathy in an Adolescent and Young Adult Patient with Acute Lymphoblastic Leukemia
por: Teshima, Kazuaki, et al.
Publicado: (2021)

Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia
por: Hao, Qishan, et al.
Publicado: (2022)

Erratum: Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines
Publicado: (2023)

Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia
por: Karpa, Vasiliki, et al.
Publicado: (2023)

High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance
por: Chen, Aaron R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1rbsmumebkcp4nu66b24q891rr